unsubscribe | view this newsletter online | full newsletter
3rd June 2011
TREAT-NMD International Conference

Registration and abstract submission are open for the TREAT-NMD international conference in Geneva, November 2011.

IDMC-8: 8th International Myotonic Dystrophy Consortium Meeting:
website and registration now open

Registration for the 8th International Myotonic Dystrophy Consortium Meeting is now live on the new conference website. Running from the 30th November to the 3rd December 2011 and taking place in Clearwater, Florida, the IDMC-8 meeting is not only designed to provide a forum for scientific presentations and discussions on the latest results in DM pathogenesis and therapy development but also to promote interactions between clinicians, basic scientists, patients and their families.

IDMC-8 is followed by EMPOWER2011, the Myotonic Dystrophy Foundation Family Conference which runs from 2nd - 4th December at the same venue.

An additional satellite meeting "Outcome Measures for Myotonic Dystrophy" is scheduled for Wednesday 30th November.

The abstract deadline for the full conference is 15th August.

Job opportunity: ENMC Research Manager
back to top    

The European NeuroMuscular Centre is seeking a new research manager to co-ordinate core and networking activities.

This position is open to applications until 24th June.

Main responsibilties include supervision and support of the ENMC organizational infrastructure and its related initiatives, co-ordination of financial and office activity, implementation and monitoring of policy development and acting as a representative of the ENMC, its aims, methods and activities.

Further details of this post and how to apply can be found on the ENMC website.

Ninth WMS Satellite Teaching Course:
registration and programme now available
back to top    

As a prequel to the main World Muscle Society congress, this satellite teaching course is taking place on Monday 17th and Tuesday 18th October 2011 in Lisbon, Portugal.

The scientific programme is now available and registration for this two day course is now open.

The course is designed to improve medical professionals' skills in the diagnosis of neuromuscular diseases and is aimed at medical specialists (paediatricians, neurologists, paediatric neurologists, geneticists, neuropathologists) and medical specialists in training, and also other attendees of the WMS congress.

Call for international collaborative project on SMA biomarkers:
first JPND call launched
back to top    

The first Joint Programme for Neurodegenerative Diseases (JPND) joint transnational call has been launched between 20 European countries, to encourage novel approaches to the development of optimally informative biomarkers and harmonisation of their use.

The aim of this call is to establish multi-national, collaborative research projects that will add value to existing research through addressing novel approaches to improve and harmonise the use of biomarkers in selected neurodegenerative disorders. Eligible disorders include SMA and ALS as well as more common neurodegenerative conditions.

Whilst applications will be submitted jointly by groups from different countries, individual research groups will be funded by the individual JPND funding organisation(s) for their country.

The deadline for applications is 5th September 2011

Further details can be found on the JPND website

OrphaData launched:
free-access data from Orphanet now in downloadable form
back to top    

Orphanet, the pan-European rare disease and orphan drug information portal, has just launched a comprehensive, high-quality and freely-accessible dataset related to rare diseases and orphan drugs in a reusable format.

The dataset is a partial extraction of the data stored in Orphanet, which is also accessible at www.orpha.net for consultation purposes only. This freely accessible dataset is available in six languages (English, French, German, Italian, Portuguese and Spanish). It includes:

  • An inventory of rare diseases, cross-referenced with OMIM, ICD-10 and with genes in HGNC, OMIM, UniProtKB and Genatlas
  • A classification of rare diseases established by Orphanet, based on published expert classifications
  • Epidemiology data related to rare diseases in Europe (class of prevalence, average age of onset, average age at death) extracted from the literature
  • A list of signs and symptoms associated with each disease, with their frequency class within the disease
Upcoming meetings
Past newsletters
TREAT-NMD conference 2011
3rd June 2011
TREAT-NMD newsletter - 3rd June 2011
unsubscribe | view this newsletter online | full newsletter